New Times,
New Thinking.

  1. Business
29 June 2012

Vince Cable warned us about Bob Diamond

The business secretary expressed reservations about the Barclays chief on his appointment two years ago.

By Richard Morris

Here are a couple of remarks from Vince Cable.

“We are worried about this combination of the casinos and the traditional banking.”

“Mr Diamond illustrates in a particularly graphic way what happens when you have an extremely high paid head of an investment bank taking over one of these major international banks.”

They don’t seem especially unusual over the last few days do they? The sort of thing you might expect any politician to be saying at the moment. And of course they echo a sentiment that I suspect is shared by many today.

Only Vince didn’t say them yesterday. Nor indeed this week. He said them almost two years ago, on Bob Diamond’s initial appointment.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

I know I’m partisan. But this does seem especially prescient, does it not? And not the sort of thing you’d expect George Osborne to say, or indeed be capable of saying.

Nor is it the first time he has been so discerning. Nor indeed, is it the second. In fact, it’s a bit of a habit.

And when it’s combined with the courage to ask the awkward questions – well, it’s the sort of judgement you’d want in a Chancellor of the Exchequer.

Isn’t it?

 

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines